These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9049526)
1. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model. Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526 [TBL] [Abstract][Full Text] [Related]
2. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension]. Schmidt BM; Smilde J; Oldenbroek C; Wehling M Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837 [TBL] [Abstract][Full Text] [Related]
3. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril. Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020 [TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure]. Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945 [TBL] [Abstract][Full Text] [Related]
5. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. Culy CR; Jarvis B Drugs; 2002; 62(2):339-85. PubMed ID: 11817979 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. Frishman WH; Greenberg S Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis. Swartz RD; Starmann B; Horvath AM; Olson SC; Posvar EL J Clin Pharmacol; 1990 Dec; 30(12):1136-41. PubMed ID: 2273086 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure. Sedman AJ; Posvar E Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762 [TBL] [Abstract][Full Text] [Related]
9. The management of hypertension in older patients. Schnaper HW J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408 [TBL] [Abstract][Full Text] [Related]
10. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
11. Quinapril: a new second-generation ACE inhibitor. Cetnarowski-Cropp AB DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension]. De Cesaris R; Ranieri G; Andriani A; Chiarappa R Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253 [TBL] [Abstract][Full Text] [Related]
13. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study. Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729 [TBL] [Abstract][Full Text] [Related]
14. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril. Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171 [TBL] [Abstract][Full Text] [Related]
15. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses. Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment. Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure. Begg EJ; Robson RA; Ikram H; Richards AM; Bammert-Adams JA; Olson SC; Posvar EL; Reece PA; Sedman AJ Br J Clin Pharmacol; 1994 Mar; 37(3):302-4. PubMed ID: 8198942 [TBL] [Abstract][Full Text] [Related]
18. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. Materson BJ Am J Cardiol; 1992 Apr; 69(10):46C-53C. PubMed ID: 1546639 [TBL] [Abstract][Full Text] [Related]
19. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording. MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis. Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]